-

Pharmaceutical Excipients Market Research Business Report 2025: Rising Demand for Generic Drugs Strengthens Business Case for Excipients - Global Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Excipients - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Pharmaceutical Excipients was valued at USD 10.2 Billion in 2024 and is projected to reach USD 13.3 Billion by 2030, growing at a CAGR of 4.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Pharmaceutical excipients play a pivotal role in the pharmaceutical industry by enhancing the properties of active pharmaceutical ingredients (APIs) without interfering with their therapeutic effects. Excipients serve various purposes, such as improving the taste and appearance of the final product, ensuring the stability and bioavailability of the drug, and facilitating drug absorption.

What Factors Are Driving Growth in the Pharmaceutical Excipients Market?

The growth in the pharmaceutical excipients market is driven by several factors. Firstly, the increasing demand for innovative drug formulations, including controlled-release and targeted delivery systems, is propelling the need for advanced excipients. Technological advancements, such as nanotechnology and 3D printing, are enabling the development of sophisticated excipients that enhance drug performance. Secondly, the rising prevalence of chronic diseases and the growing geriatric population are boosting the demand for pharmaceuticals, thereby expanding the excipient market.

Additionally, the trend towards personalized medicine and the development of biologics and biosimilars are creating new opportunities for specialized excipients. Regulatory requirements for drug safety and quality are also driving the adoption of high-purity and compliant excipients. Furthermore, the focus on sustainability and green chemistry in pharmaceutical manufacturing is encouraging the use of eco-friendly excipients. Lastly, increasing R&D investments by pharmaceutical companies to develop novel drug delivery systems and improve existing formulations are fueling market growth. These factors collectively contribute to the dynamic expansion and innovation within the pharmaceutical excipients market.

How Are Technological Advancements Shaping the Excipient Landscape?

Technological advancements have dramatically transformed the landscape of pharmaceutical excipients, driving innovation and improving the quality of drug formulations. One significant development is the advent of multifunctional excipients that combine several properties into a single substance, reducing the need for multiple additives and streamlining the manufacturing process. Advances in nanotechnology have also led to the creation of nano-sized excipients that enhance drug solubility and bioavailability, particularly for poorly water-soluble drugs.

Moreover, the integration of 3D printing technology in pharmaceuticals has opened new avenues for personalized medicine, where excipients are tailored to individual patient needs and specific drug release profiles. The use of sophisticated analytical techniques, such as spectroscopy and chromatography, ensures the purity and consistency of excipients, thereby maintaining high-quality standards in drug production. These technological innovations not only improve the performance of excipients but also support the development of more effective and safer medications.

What Role Do Regulatory Standards and Sustainability Play in the Excipient Market?

Regulatory standards and sustainability are pivotal factors influencing the pharmaceutical excipient market. Regulatory bodies, such as the FDA and EMA, impose stringent guidelines on the use of excipients to ensure their safety, efficacy, and quality. Compliance with these regulations is mandatory for pharmaceutical companies, prompting continuous improvement and rigorous testing of excipients. Additionally, there is a growing emphasis on the sustainability of excipients, driven by environmental concerns and consumer demand for eco-friendly products.

Manufacturers are increasingly adopting green chemistry principles, utilizing renewable resources, and minimizing waste in excipient production. The development of biodegradable and non-toxic excipients aligns with global sustainability goals and reduces the environmental impact of pharmaceutical manufacturing. Furthermore, transparency in the supply chain and adherence to good manufacturing practices (GMP) are crucial for maintaining the integrity and trustworthiness of excipient suppliers. These regulatory and sustainability trends ensure that the excipient market evolves in a responsible and forward-thinking manner.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in USD from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Archer Daniels Midland Company, Ashland Global Holdings Inc., Associated British Foods PLC, BASF SE, Croda International PLC and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Organic Chemicals segment, which is expected to reach $9.8 Billion by 2030 with a CAGR of a 4.5%. The Inorganic Chemicals segment is also set to grow at 5.1% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $2.8 Billion in 2024, and China, forecasted to grow at an impressive 4.3% CAGR to reach $2.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Segments

  • Type (Organic Chemicals, Inorganic Chemicals, Other Types)
  • Formulation (Oral, Topical, Parenteral, Other Formulations)
  • Functionality (Fillers & Diluents, Binders, Suspending & Viscosity Agents, Flavoring Agents & Sweeteners, Other Functionalities)

Key Attributes:

Report Attribute Details
No. of Pages 205
Forecast Period 2024 - 2030
Estimated Market Value (USD) in 2024 $10.2 Billion
Forecasted Market Value (USD) by 2030 $13.3 Billion
Compound Annual Growth Rate 4.5%
Regions Covered Global 

Key Topics Covered:

MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Pharmaceutical Excipients - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Global Economic Update

MARKET TRENDS & DRIVERS

  • Increasing Demand for High-Quality Excipients Propels Market Growth
  • Technological Advancements in Excipient Formulation Enhance Product Performance
  • Rising Focus on Drug Delivery Systems Expands Addressable Market Opportunity
  • Growth in Biopharmaceuticals Drives Demand for Specialized Excipients
  • Increasing Investment in Pharmaceutical R&D
  • Advances in Functional Excipients for Improved Drug Stability
  • Development of Novel Excipients for Targeted Drug Delivery
  • Rising Demand for Generic Drugs Strengthens Business Case for Excipients
  • Expansion of Global Pharmaceutical Industry Drives the Market
  • Growth in Personalized Medicine and Customized Formulations
  • Increasing Focus on Patient Compliance and Convenience
  • Increasing Applications in Advanced Drug Formulation Technologies

FOCUS ON SELECT PLAYERS: Some of the major companies featured in this report

  • Archer Daniels Midland Company
  • Ashland Global Holdings Inc.
  • Associated British Foods PLC
  • BASF SE
  • Croda International PLC
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Innophos Holdings, Inc.
  • Kerry Group PLC
  • Roquette
  • Signet Chemical Corporation Pvt. Ltd.
  • The Lubrizol Corporation
  • Wacker Chemie AG

For more information about this report visit https://www.researchandmarkets.com/r/m6qjhb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Loyalty Programs Market Intelligence and Future Growth Dynamics Report 2025 | Subscription-Based and Sustainability-Linked Loyalty Programs Set to Dominate Global Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Loyalty Programs Market Intelligence and Future Growth Dynamics - 50+ KPIs on Loyalty Programs Trends by End-Use Sectors, Operational KPIs, Retail Product Dynamics, and Consumer Demographics - Q1 2025 Update" report has been added to ResearchAndMarkets.com's offering. The global loyalty market is expected to grow by 15.9% on annual basis to reach US$93.79 billion in 2025. In value terms, the global loyalty market has recorded a CAGR of 17.8% during 2020-2024. The g...

Meal Replacement Products Market Focused Insights 2025-2030, With Key Vendor Profiles for Abbott, Glanbia, Herbalife International of America, Nestle and Kellanova - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Meal Replacement Products Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Meal Replacement Products Market was valued at USD 13.79 billion in 2024, and is projected to reach USD 21.30 billion by 2030, rising at a CAGR of 7.52%. The global meal replacement products market is set to grow due to rising health consciousness and the growing popularity of plant-based & vegan meal replacement options. The global mea...

Connected Commercial Drones Report 2025 - The Number of Connected Commercial Drones Reached 2.8 Million Units Worldwide in 2024 and is Set to Reach 4.5 Million Units by 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Connected Commercial Drones - 1st Edition" report has been added to ResearchAndMarkets.com's offering. The research estimates that the installed base of commercial drones reached 2.8 million units worldwide in 2024. The installed base includes connected drones in the agriculture, military and defence, public safety and first response, and surveying and inspection application areas. In the agricultural sector, drones used for both aerial imagery and crop spraying op...
Back to Newsroom